Posted in | News

International Builders Show to Display PPG’s CLARVISTA Shower Glass

PPG Industries will showcase low-emissivity and passive solar glass samples at the International Builders Show for 2012 in Orlando, which is to be held on Feb. 8-11 of 2012. The company will also display a dual-coat, dual-pane insulating glass unit (IGU) and CLARVISTA shower glass, facilitating the housing windows to attain the R-5 “center-of-glass” insulating performance.

CLARVISTA glass

This new low-e, passive solar glass from PPG has been designed in such a way that it can be used for residential purposes during the heating-dominated and cold climates. The company will officially launch the product during early 2012.

In addition, the company will exhibit Clarvista glass, which is a shower enclosure and door glass that seems to be newer than the competing products. The Clarvista glass is made of a coating, which seals the surface of the glass. It can resist corrosion due to humidity and heat. This glass has created a very transparent shower glass when joined with STARPHIRE ultra-clear glass and is suitable for commercial spa, resorts and upscale homes.

PPG will display an IGU, which is manufactured using SOLARBAN 60 glass on the second surface and a 3 mm new low-e, solar glass pane on the fourth surface. R-5 insulating performance has been obtained at the glass’s center through this pattern.

The federal legislation accentuates the U-value of 0.22 or less for these R-5 windows, which is then adopted for building codes in order to advance the energy efficiency of multi-family residential houses and single-family homes.

The dual-coat, dual-pane technology of PPG has helped the window makers to manufacture good insulating products devoid of multi-cavity IGUs that may cause difficulties in the manufacturing methods and add to the window cost for builders, homeowners and remodelers.

Source: http://www.ppg.com/en/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). International Builders Show to Display PPG’s CLARVISTA Shower Glass. AZoBuild. Retrieved on November 22, 2024 from https://www.azobuild.com/news.aspx?newsID=14682.

  • MLA

    Scanlon, Joel. "International Builders Show to Display PPG’s CLARVISTA Shower Glass". AZoBuild. 22 November 2024. <https://www.azobuild.com/news.aspx?newsID=14682>.

  • Chicago

    Scanlon, Joel. "International Builders Show to Display PPG’s CLARVISTA Shower Glass". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14682. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. International Builders Show to Display PPG’s CLARVISTA Shower Glass. AZoBuild, viewed 22 November 2024, https://www.azobuild.com/news.aspx?newsID=14682.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.